Your browser doesn't support javascript.
loading
Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy.
Higgins, Angela Y; Annapureddy, Amarnath R; Wang, Yongfei; Minges, Karl E; Bellumkonda, Lavanya; Lampert, Rachel; Rosenfeld, Lynda E; Jacoby, Daniel L; Curtis, Jeptha P; Miller, Edward J; Freeman, James V.
Afiliação
  • Higgins AY; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Annapureddy AR; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT; Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, CT.
  • Wang Y; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT; Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, CT.
  • Minges KE; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT; Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, CT; Department of Health Administration and Policy, University of New Haven, Wes
  • Bellumkonda L; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Lampert R; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Rosenfeld LE; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Jacoby DL; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Curtis JP; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT; Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, CT.
  • Miller EJ; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
  • Freeman JV; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT; Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, CT. Electronic address: james.freeman@yale.edu.
Am Heart J ; 246: 21-31, 2022 04.
Article em En | MEDLINE | ID: mdl-34968442
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Sarcoidose / Desfibriladores Implantáveis / Insuficiência Cardíaca / Miocardite Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Sarcoidose / Desfibriladores Implantáveis / Insuficiência Cardíaca / Miocardite Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2022 Tipo de documento: Article